Morgan Stanley Pmv Pharmaceuticals, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Morgan Stanley holds 59,421 shares of PMVP stock, worth $95,667. This represents 0.0% of its overall portfolio holdings.

Number of Shares

59,421

Previous 119,237 50.17%

Holding current value

$95,667

Previous $193,000 54.4%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.44 - $1.69 $86,135 - $101,089	-59,816 Reduced 50.17%	59,421 $88,000
Q2 2024 Oct 17, 2024	SELL	$1.51 - $2.21 $456,912 - $668,726	-302,591 Reduced 71.73%	119,237 $193,000
Q2 2024 Aug 14, 2024	SELL	$1.51 - $2.21 $456,912 - $668,726	-302,591 Reduced 71.73%	119,237 $193,000
Q1 2024 Oct 17, 2024	BUY	$1.51 - $3.12 $456,912 - $944,083	302,591 Added 253.77%	421,828 $717,000
Q1 2024 Aug 16, 2024	BUY	$1.51 - $3.12 $34,201 - $70,668	22,650 Added 5.67%	421,828 $717,000
Q1 2024 May 15, 2024	BUY	$1.51 - $3.12 $34,201 - $70,668	22,650 Added 5.67%	421,828 $717,000
Q4 2023 Aug 16, 2024	BUY	$1.23 - $6.6 $344,327 - $1.85 Million	279,941 Added 234.78%	399,178 $1.24 Million
Q4 2023 Feb 13, 2024	BUY	$1.23 - $6.6 $201,546 - $1.08 Million	163,859 Added 69.63%	399,178 $1.24 Million
Q3 2023 Nov 15, 2023	SELL	$6.01 - $8.93 $724,968 - $1.08 Million	-120,627 Reduced 33.89%	235,319 $1.44 Million
Q2 2023 Aug 14, 2023	SELL	$3.94 - $6.27 $1.08 Million - $1.72 Million	-274,313 Reduced 43.52%	355,946 $2.23 Million
Q1 2023 May 15, 2023	SELL	$4.77 - $9.16 $2.43 Million - $4.66 Million	-509,003 Reduced 44.68%	630,259 $3.01 Million
Q4 2022 Feb 14, 2023	SELL	$8.17 - $12.95 $1.43 Million - $2.26 Million	-174,641 Reduced 13.29%	1,139,262 $9.91 Million
Q3 2022 Nov 14, 2022	SELL	$11.4 - $17.18 $20.2 Million - $30.4 Million	-1,772,060 Reduced 57.42%	1,313,903 $15.6 Million
Q2 2022 Oct 27, 2022	SELL	$9.23 - $22.43 $12 Million - $29.2 Million	-1,303,107 Reduced 29.69%	3,085,963 $44 Million
Q2 2022 Aug 15, 2022	SELL	$9.23 - $22.43 $12 Million - $29.2 Million	-1,303,107 Reduced 29.69%	3,085,963 $44 Million
Q1 2022 Oct 27, 2022	BUY	$14.86 - $23.55 $19.4 Million - $30.7 Million	1,303,107 Added 42.23%	4,389,070 $91.4 Million
Q1 2022 May 13, 2022	BUY	$14.86 - $23.55 $60.4 Million - $95.7 Million	4,063,103 Added 1246.48%	4,389,070 $91.4 Million
Q4 2021 Feb 14, 2022	BUY	$19.99 - $30.24 $5.76 Million - $8.71 Million	288,078 Added 760.32%	325,967 $7.53 Million
Q3 2021 Nov 15, 2021	BUY	$26.84 - $36.58 $1.02 Million - $1.39 Million	37,889 New	37,889 $1.13 Million

Others Institutions Holding PMVP

# of Institutions

Shares Held

41.9M

Call Options Held

3.1K

Put Options Held

1.7K

View Full List

About PMV Pharmaceuticals, Inc.

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $73.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

More about PMVP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account